In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...

American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states ...

When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...

A new study led by scientists from the Northwestern Medicine Canning Thoracic Institute and published in the Journal of ...